The executive released the regulation that regulates the medical and therapeutic use of cannabis and its derivatives. The document consists of 14 chapters, 50 articles and 14 complementary provisions in order to benefit thousands of patients who need this contribution for their medical treatments.
Ica declares an epidemiological alert to the increase in dengue fever cases
The province of Ica has reported 151 cases out of the 238 cases recorded in the region.
He Ministry of Health (Minsa), by Directorate General for Medicines, Supplies and Medicines (Digemid), the Directorates of Integrated Health Networks or those who act in their place, as competent authorities, will be responsible for issuing licenses for the production, import, marketing and licenses for the artisanal production of cannabis derivatives with associative cultivation of the plant of the genus cannabis.
There Mediator He highlighted the approval and publication of the settlement and recalled that the settlement had been pending for over a year.
The entity in charge of National Registry of Patients Using Cannabis and its Derivatives for Medical and Therapeutic Use (RENPUC) is the Digemid. In order for a patient to be registered in the registry, he must submit a virtual affidavit on the Digemid web portal with information about the disease, the attending physician, the dose and the frequency of treatment.
The regulations state that only surgeons are authorized to prescribe cannabis derivatives for medicinal and therapeutic purposes by a medical prescription which must contain the following information:
Leukemia, the most common type of cancer among miners in Peru
According to the Medical College of Peru, there are only 37 pediatric oncologists to care for all infants in the country. GlobeLiveMedia spoke with the specialist Ana María Gloria Paredes, who gave more details about this pathology.
– Surnames and first names of the surgeon, school number, telephone number and address.
– Surnames and first names, address, telephone number and patient identifier.
More than 6,000 patients are waiting for an organ donor
Although the organ donor rate in Peru has increased, it remains insufficient to meet the long waiting list. One donor can save the lives of up to 10 people.
– Medical diagnosis.
– Name of the cannabis derivative and its international nonproprietary name, if applicable.
– Details of the active ingredient, duration of treatment and number of units per injection per day.
Additionally, it is required that The validity of the prescription will be 30 days.from its issue and once the product has been issued, the prescription will be kept by the apothecary or pharmacy, depositing the document for two years.
The regulations indicate the types of licenses that can be issued for the medical and therapeutic use of cannabis and its derivatives. The validity period of the licenses granted is indefinite and must be granted within a period not exceeding 30 days.
License for scientific research: It is exclusive to universities and institutions that conduct agricultural and health research and health science research for medicinal purposes.
Import and marketing license: It is granted to pharmaceutical laboratories, drugstores, pharmacies, apothecaries and pharmacies in health establishments.
Manufacturing license: It is granted only to public entities or pharmaceutical laboratories.
Craft production license: it is granted to duly accredited and certified patient associations.
The regulations specify that the Cannabis Patient Associations They may be composed of two or more patients or legal representatives, previously registered with RENPUC. In addition, they must be accredited and certified.
In interview with RPP News, Digemid specialist in controlled product issues, Judith Castaneda explained that the regulation gives duly accredited patient associations the possibility of developing their own cannabis derivatives for medical and therapeutic use.